During myocardial ischemia/reperfusion, mitochondria are both a source and a target of injury. In cardioprotective maneuvers such as ischemic and pharmacological pre-and postconditioning mitochondria have a decisive role. Since about 99% of the mitochondrial proteins are encoded in the nucleus, deleterious and protective mitochondrial effects most likely comprise the import of cytosolic proteins. The present review therefore discusses the role of mitochondria in myocardial ischemia/reperfusion injury and protection from it, focusing on some cytosolic proteins, which are translocated into mitochondria before, during, or following ischemia/reperfusion. Both morphological and functional alterations are discussed at the level of the heart, the cardiomyocyte and/or the mitochondrion itself. This article is part of a Special Issue entitled: Mitochondria and Cardioprotection.
The mitochondrial proteome
Mitochondria contain their own DNA as a small circular molecule of about 16 kb. The mitochondrial DNA only encodes 2 rRNAs, 22 tRNAs, and 13 proteins which serve as subunits of the respiratory chain. During evolution many mitochondrial genes have been transferred to the cell nucleus and now the majority of mitochondrial proteins is encoded in the nuclear DNA.
The development of mass spectrometry-based techniques allowed the identification and characterization of these nuclear-encoded mitochondrial proteins. A recent large-scale analysis of the murine cardiac proteome using gel-free shotgun sequencing of subcellular protein fractions resulted in the identification of about 4900 proteins in total, of which around 650 proteins were allocated to the mitochondrial matrix and around 850 to the mitochondrial membranes [27] . In a recent study on purified mouse cardiac mitochondria, 940 distinct proteins were identified using liquid chromatography tandem mass spectrometry (LC/MS/MS), of which 480 proteins were not previously recognized as mitochondrial proteins by proteomic profiling [138] . Of these 940 proteins, only 59 were classified as proteins of "unknown function". Around 80% of the 615 proteins of the human heart mitochondrial proteome identified by matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) and LC/MS/MS analysis function in oxidative phosphorylation, RNA, DNA, and protein synthesis, ion transport and metabolism; however, the function of around 20% of the human mitochondrial proteins has not been defined yet [124] . A further identification of the mitochondrial proteome and the associated protein function will contribute to our understanding of the importance of mitochondria for myocardial morphology and function under physiological and pathophysiological conditions, independent from and in addition to their utmost importance in energy production.
Protein import into mitochondria
Since more than 99% of the mitochondrial proteins are synthesized in the cytosol, the majority of the mitochondrial proteins has to be imported. Detailed information on the components and pathways of the mitochondrial import machineries is summarized in recent reviews [31, 50] .
In the cytosol, preproteins are kept soluble by interactions with molecular chaperones such as heat shock protein 90 (Hsp90) or heat shock cognate 70 (Hsc70). The chaperones guide the preproteins to the mitochondrion, where they interact with the mitochondrial outer membrane translocase (Tom) complex [51] . The Tom complex is the main protein entry gate of the mitochondria. The proteins Tom20, Tom22, and Tom70 function as presequence receptors and detect mitochondrial targeting signals of cytosolic preproteins. Tom40 forms the channel for preprotein import across the outer mitochondrial membrane. Following passage of the Tom40-formed channel, different complexes direct the preproteins to their final destination in the different mitochondrial compartments. The proteins of the translocase of the inner membrane (Tim) complex transport preproteins across the inner membrane. To direct preproteins into the mitochondrial matrix, Tim23 interacts with the presequence associated motor (Pam) complex. Most proteins without cleavable presequences are translocated to the inner membrane via the Tim22 complex or to the outer membrane via the topogenesis of mitochondrial outer membrane β-barrel proteins/sorting and assembly machinery (Tob/Sam) complex. Protein import into the intermembrane space is facilitated by the Tim40/mitochondrial intermembrane space import and assembly (Mia) complex. Alternatively, mitochondrial-or nuclearencoded proteins can be directed from the matrix to the inner membrane by the oxidase assembly (Oxa) pathway.
Cleavable presequences, typically 5-20 amino acid residues in length at the amino terminus of the preprotein, represent the classical type of mitochondrial targeting signals. The presequence receptors of the Tom complex contain receptor domains for the detection of cytosolic presequences, which, upon interaction with the presequence receptor, form an α-helical structure. Most of these presequences are removed in the mitochondrial matrix by mitochondrial processing peptidases. A hydrophobic sorting signal adjacent to the α-helical presequence induces the stop of the protein translocation process in the inner membrane. Proteins with a destination at the inner membrane are anchored, and inner membrane peptidases cleave the sorting signal of the preproteins with a destination in the intermembrane space. Several proteins, among them mostly outer membrane proteins and proteins of the intermembrane space, contain internal, non-cleavable targeting signals. These signals are neither conserved in their location within the proteins nor in their amino acid composition.
Taken together, translocation of nuclear-encoded proteins into mitochondria is determined by an interplay of mitochondrial targeting signals with different protein complexes of the import machinery.
Mitochondria in ischemia/reperfusion injury
During normoxia, mitochondria consume large amounts of oxygen to produce ATP at complex V of the respiratory chain. When the heart becomes ischemic, the electron flow along the respiratory complexes is inhibited and mitochondrial oxygen consumption as well as ATP production decrease [18, 77, 101] . Instead, myocardial ATP produced in the cytosol by anaerobic glycolysis is now consumed by mitochondria to maintain their inner membrane potential. At reperfusion in still viable cells, oxidative phosphorylation is restored, ATP production increases and may contribute to the reestablishment of cellular ion homeostasis. However, increased ATP production may paradoxically also contribute to reperfusion injury. During ischemia, the cardiomyocyte cytosol becomes overloaded with calcium (Ca 2+ Here, also intracellular communication between the sarcoplasmatic reticulum and mitochondria seems to be involved [110] . Apart from ATP, mitochondria also generate reactive oxygen species (ROS) [8, 49, 90] . Within mitochondria, ROS originate from different sources, one of them is the respiratory chain itself, mainly complexes I and III. Here, electrons from the electron transport chain can be transferred to oxygen, which results in the formation of superoxide anions. ROS are also produced by monoamine oxidases located at the outer mitochondrial membrane, which transfer electrons from amine compounds to oxygen leading to hydrogen peroxide formation [52] . Furthermore, the cytosolic protein p66 Shc becomes phosphorylated under stress conditions and shuttles into the mitochondrial intermembrane space, where it oxidizes reduced cytochrome c resulting in peroxide formation [54] .
ROS formation increases during ischemia [12, 131] , and a further burst of ROS occurs in early reperfusion [73, 101] . Increased ROS formation is causally involved in cell death after ischemia/reperfusion [1, 12, 75, 106, 128, 131] , and ROS scavenging at reperfusion reduces reversible and irreversible cellular injury [130] . Accordingly, hearts from p66
Shc knockout mice are protected from ischemia/reperfusion injury in vitro [30, 47] , and inhibition of monoamine oxidase reduces infarct size following ischemia/reperfusion injury in vivo [13] . The burst of ROS at the onset of reperfusion facilitates opening of the mitochondrial permeability transition pore (MPTP), a large conductance pore in the inner mitochondrial membrane. MPTP opening at reperfusion enhances inner mitochondrial membrane permeability to solutes with molecular weights up to 1.5 kDa and leads to mitochondrial depolarization and subsequently to ATP depletion [46] . Mitochondrial matrix volume increases and induces rupture of the outer mitochondrial membrane. This leads to loss of pyridine nucleotides and thereby to the inhibition of electron flow along the protein complexes of the electron transport chain. MPTP opening is facilitated by Ca 2+ ions, inorganic phosphate and mitochondrial depolarization, i.e., conditions occurring during ischemia and reperfusion [45, 66] . In contrast, MPTP opening is delayed at increased mitochondrial membrane potentials, high concentrations of protons, magnesium ions, adenine nucleotides, and nitric oxide [45, 132] . The traditional hypothesis that the MPTP is formed by the voltage-dependent anion channel (VDAC) in the outer membrane, the adenine nucleotide transporter (ANT) in the inner membrane, and cyclophilin D in the matrix has recently been challenged, since experiments on VDAC and ANT knockout mitochondria displayed effective calcium-induced MPTP opening [6, 74] . Knockout of cyclophilin D delays calcium-induced MPTP opening of isolated liver and cardiac mitochondria [5, 10] and protects fibroblasts from H 2 O 2 -induced loss of mitochondrial membrane potential [5] . However, cyclophilin D-deficiency has no effect on MPTP opening in isolated mitochondria in the presence of diamide, which acts through the redox-sensitive dithiol [10] , and in response to adenine nucleotides, suggesting that the MPTP can also open in the absence of cyclophilin D [10] . Whereas cardiomyocyte death after ischemia/reperfusion is mainly necrotic, mitochondrial apoptotic pathways are also initiated by ischemia/reperfusion. Loss of mitochondrial membrane potential and matrix swelling caused by MPTP opening induce the release of the pro-apoptotic protein cytochrome c from the intermembrane space into the cytosol, which ultimately leads to the activation of caspasemediated apoptosis [140] .
Ischemia/reperfusion and cardioprotective interventions impact on mitochondrial morphology and the inter-mitochondrial network, i.e., fusion and fission [28, 97] . Mitochondrial fusion proteins include the outer membrane proteins mitofusin (Mfn) 1 and 2 and the inner membrane protein optic atrophy protein 1 (Opa1). Mitochondrial fission proteins are the dynamin-related protein 1 (Drp1), which is recruited from the cytosol to the mitochondria, and the outer membrane protein human mitochondrial fission protein 1 (hFis1) (for a review, see [48] ). Decreasing mitochondrial fission is cardioprotective, since a Drp1 inhibitor reduces cardiomyocyte death following ischemia/reperfusion both in vitro and in vivo [98] .
Apart from its involvement in mitochondrial fusion, Mfn2 is also localized at the contact sites between the mitochondria and the endoplasmic reticulum and Mfn2 deficiency reduces mitochondrial Ca 2+ uptake by increasing the distance between the endoplasmic reticulum and the mitochondria [44] .
Release of ROS or pro-apoptotic factors from damaged mitochondria enhances cardiomyocyte injury. Although mitochondrial fusion is viewed as a mitochondrial repair mechanism, irreversibly damaged mitochondria need to be removed by mitophagy and indeed, the elimination of damaged mitochondria by mitophagy is cardioprotective [57] .
Taken together, whereas ischemia and reperfusion damage mitochondria (e.g., limited oxidative phosphorylation), mitochondria themselves may contribute to myocardial injury (e.g., MPTP openinginduced cell death) [65, 66] .
Mitochondrial proteins contributing to the cardioprotection by pre-and postconditioning
Infarct size after ischemia/reperfusion can be reduced by cardioprotective maneuvers such as ischemic pre-and postconditioning. In ischemic preconditioning, infarct size following sustained ischemia and reperfusion is decreased by preceding, non-lethal episodes of ischemia/reperfusion [91] , whereas in ischemic postconditioning, the brief cycles of ischemia and reperfusion are employed at the immediate onset of reperfusion [139] . Both pre-and postconditioning can be mimicked pharmacologically. The signal transduction cascades of these cardioprotective phenomena, especially that of preconditioning, have been extensively studied, and it has become clear that different pathways finally target the mitochondria and that preservation of mitochondrial function is central for cardioprotection [19, 63, 66, 89, 99] .
The proper analysis of the import of nuclear-encoded proteins into the mitochondria after ischemia/reperfusion clearly depends on the purity of the mitochondrial preparations. A crude mitochondrial preparation can be obtained by differential centrifugation; however, a pure mitochondrial preparation requires additional ultracentrifugation using sucrose-or Percoll-gradients. In most cases, the purity of the mitochondrial preparations is demonstrated by the absence of marker proteins of subcellular compartments in the mitochondrial fraction by Western blot analysis. Using immuno-electron and confocal microscopy, a direct mitochondrial localization can be shown. In addition, proteins located in the inner mitochondrial membrane or the mitochondrial matrix are detectable in mitochondrial subfractions, in which proteins of the outer membrane and the intermembrane space are removed, whereas contaminating proteins are no longer traceable in these preparations [21, 107] .
In the present review, we will discuss nuclear-encoded proteins, which are imported into the mitochondria and exert their cardioprotective function by modulating mitochondrial structure and/or function.
Proteins of the mitochondrial import machinery
Under conditions that require mitochondrial biogenesis and hence increased levels of mitochondrial proteins, protein import into the mitochondria is enhanced [122] . Mitochondrial protein import is partially dependent on the contents of proteins constituting the import machinery; accordingly, overexpression of the presequence receptor Tom20 increases and inhibition of Tom20 decreases mitochondrial protein import [60, 86] . In pig myocardium, the mitochondrial Tom20 content during reperfusion is reduced by ischemia and ischemic preconditioning preserves the mitochondrial Tom20 content. Ischemic preconditioning has, however, no effect on the amounts of Tom40 and Tim23 [17] . The preservation of the Tom20 content by preconditioning may contribute to the maintenance of mitochondrial proteins needed for proper post-ischemic mitochondrial function.
Mitochondrial heat shock protein 70 (Hsp70) in the matrix interacts with Tim44 and thereby generates a "pulling" force, which supports unfolding of proteins during translocation [133] . Adenoviral transfection of neonatal cardiomyocytes with mitochondrial Hsp70 increases the activities of protein complexes of the electron transport chain and cellular ATP content, and it improves cell viability following simulated ischemia and reoxygenation [135] . Protein import into mitochondria is terminated by proper protein folding and Hsp60 and Hsp10 are the major sites of protein folding in mitochondria. Overexpression of Hsp60 and Hsp10 confers protection in isolated cardiomyocytes during simulated ischemia [68, 76] and increases the activities of complexes of the electron transport chain [79] . Transfection of cells with a mutant Hsp10, which renders the protein incapable of interacting with Hsp60, increases cell death after simulated ischemia/reoxygenation and decreases the activity of complex II of the electron transport chain [78] .
Taken together, enhanced contents of proteins of the import machinery involved in presequence recognition, membrane translocation and protein folding (as achieved for example by preconditioning) increase the activities of respiratory chain complexes and preserve viability of cardiomyocytes following ischemia/reperfusion.
Proteins involved in mitochondrial energetics
In isolated rat hearts undergoing ischemia/reperfusion without and with ischemic preconditioning [136] , the majority of proteins which differ in content contribute to mitochondrial energetics such as oxidative phosphorylation, β-oxidation and ATP production. Preconditioning enhances the levels of cytochrome c oxidase subunit VIb in mitochondrial supercomplexes formed by the proteins of the electron transport chain, and maintenance of the supercomplexes is important for proper mitochondrial respiratory function [108] . The preconditioning-induced alteration in mitochondrial protein content may alter the composition of the supercomplexes of the electron transport chain proteins and may thereby impact on mitochondrial function. Pharmacological preconditioning of isolated cardiomyocytes with adenosine or diazoxide increases the amounts of 19 mitochondrial proteins in total, of which 10 proteins relate to the tricarboxylic acid cycle and oxidative phosphorylation [3] . The small number of affected proteins suggests a very specific response to pharmacological preconditioning.
Ischemic and pharmacological preconditioning alters the amounts and the posttranslational modifications of mitochondrial proteins, especially of proteins important for mitochondrial energetics.
Mitochondrial protein kinases
In the signal transduction cascades of pre-and postconditioning, cytosolic protein kinases are activated via receptor-initiated pathways or via signals originating within mitochondria, e.g., ROS [4, 42, 65] . However, also shuttling of protein kinases into mitochondria or changes in the activity of mitochondrial protein kinases are initiated by ischemia/reperfusion and/or cardioprotective interventions.
Protein kinase C epsilon (PKCε)
The ten members of the PKC protein family are classified into the conventional isoenzymes (PKCα, PKCβI, PKCβII, and PKCγ), the novel isoenzymes (PKCδ, PKCε, PKCη, and PKCθ) and the atypical isoenzymes (PKCζ and PKCλ (mouse, the human homologue is termed PKCι) according to their requirements for the second messengers diacylglycerol and Ca 2+ [92] . Despite a high structural homology, the function of the PKC isoforms is quite diverse, e.g., PKCδ enhances and PKCε reduces irreversible myocardial injury in rodents following ischemia/reperfusion [33, 69, 115] . However, in larger mammals such as pigs, PKCα seems to be the isoform involved in ischemia/ reperfusion injury and protection from it [113] . In rodents, PKCε is an important signaling element of ischemic preconditioning; pharmacological inhibition of PKCε [59, 80] or genetic deletion of the gene encoding PKCε abolishes ischemic preconditioning's cardioprotection [111] . Also, the cardioprotection by ischemic postconditioning was lost in isolated rat hearts treated with a specific PKCε inhibitor [137] . Upon a preconditioning stimulus, PKCε translocates from the cytosol to the particulate fraction [96, 103, 129] , but also to the mitochondria [96] . Whether or not postconditioning also induces mitochondrial PKCε translocation is unknown at present. Mitochondrial PKCε is located within the intermembrane space and associated with the inner mitochondrial membrane, but the presence of a second PKCε pool within the matrix has been suggested [36] . PKCε is imported into mitochondria via Hsp90 and the presequence receptor Tom20 [29] . Pharmacological inhibition of Hsp90 by geldanamycin reduces the ischemia/reperfusion-induced mitochondrial translocation of PKCε and increased necrotic cell death. On the other hand, stimulation of the PKCε/Hsp90 interaction using the novel PKCε activating peptide ψεHsp90 enhances the mitochondrial PKCε content and decreases ischemia/reperfusion injury both in vitro and in vivo [29] , demonstrating the importance of mitochondrial PKCε for cell survival. Within mitochondria, PKCε has several target proteins, and one of them is mitogen activated protein kinase (MAP kinase) [7] . Signaling modules of mitochondrial PKCε and the MAP kinase extracellular signal-regulated kinase (ERK) induce the phosphorylation and inactivation of the pro-apoptotic protein Bad [7] . PKCε also targets aldehyde dehydrogenase [34] , which contributes to cardioprotection by inhibition of toxic aldehyde formation [32] . Preconditioning increases the activity of cytochrome c oxidase, which plays a role in the maintenance of the proton gradient along the inner mitochondrial membrane and the generation of ATP; accordingly, there is increased co-immunoprecipitation of PKCε with the cytochrome c oxidase subunit IV [61] . The interaction of PKCε with connexin 43 [109] and the role of PKCε in regulating opening of the mitochondrial ATPdependent potassium channel (mitoK ATP channel) will be discussed in detail below (see paragraph 4.4).
Taken together, PKCε is important for the cardioprotection by ischemic pre-and postconditioning. Specifically mitochondrial PKCε contributes to cardioprotection by regulating the activity of several mitochondrial proteins. Whether the PKC isoform required for cardioprotection is species-dependent remains to be elucidated.
Glycogen synthase kinase 3 β (GSK3β)
Glycogen synthase kinase 3 β (GSK-3β) is important for various cellular functions, including glycogen metabolism, gene expression, and cell survival. The activity of the protein is regulated via phosphorylation; the phosphorylation of GSK3β at serine 9 renders the protein inactive. Pharmacological inhibition of GSK3β either before ischemia or before reperfusion reduces ischemia/reperfusion injury [55, 93, 125] . Both ischemic preconditioning [93, 125] and ischemic postconditioning [123] are associated with enhanced GSK3β phosphorylation in rodent hearts. In mice, in which serine 9 is replaced by alanine to render GSK3β insensitive to phosphorylation, infarct size reduction by ischemic postconditioning is lost [55] . In contrast, both ischemic pre-and postconditioning efficiently reduce infarct size in mice with inactive phosphorylation sites at serine 9 in GSK3β and serine 21 in the highly homologous isoform GSK3α, demonstrating that GSK3 phosphorylation may be dispensable for cardioprotection [95] . The divergent findings may be related to different genetic mouse strains: while Gomez et al. investigated mice in which mutated GSK3β was overexpressed and "endogenous" GSK3β could still be inhibited [55] , Nishino et al. analyzed mice with a targeted knockin of noninhibitable GSK3α and GSK3β [95] . Supporting a highly variable role of GSK3β for cardioprotection, ischemic postconditioning in pigs did not increase GSK3β phosphorylation over that by reperfusion per se [116] .
If protective, the effects of GSK3β involve mitochondrial structure and proteins, e.g., inhibition of MPTP opening [71, 72] and control of mitochondrial adenine nucleotide transport through the outer mitochondrial membrane [43] . Since GSK3β is mainly localized in the cytosol but targets mitochondrial proteins, attention has been directed to the presence and action of GSK3β within mitochondria. Ischemia/reperfusion increases the content of total and phosphorylated GSK3β in mitochondria of isolated rat hearts and enhances the protein-protein interaction between GSK3β and VDAC or ANT [94] . In rat myocardium, the phosphorylation status of mitochondrial GSK3β closely correlates with the Ca 2+ concentration needed to induce MPTP opening, suggesting that mitochondrial and not cytosolic GSK3β is involved in cardioprotection [85] . However, translocation and phosphorylation of GSK3β to/in mitochondria were not affected by ischemic preconditioning in isolated rat hearts [35] . In contrast, ischemic postconditioning was associated with enhanced mitochondrial contents of both total and phosphorylated GSK3β in isolated rat hearts [102] . In summary, whereas data on the role of GSK3β in cardioprotection using genetic models revealed contradictory results, pharmacological inhibition of GSK3β clearly abolishes cardioprotection. However, further studies are needed to distinguish between the effects of cytosolic and mitochondrial GSK3β and to specifically characterize the role of mitochondrial GSK3β in cardioprotection.
Pim-1
Pim-1 is a serine/threonine protein kinase, which belongs to the family of calmodulin-dependent protein kinases. The mitochondrial content of Pim-1 is enhanced following ischemia/reperfusion in vitro, and mitochondria isolated from hearts of Pim-1 overexpressing mice are more resistant to Ca 2+ -induced swelling than mitochondria from wild-type mice [25] . Genetic Pim-1 ablation increases myocardial infarct size after ischemia/reperfusion in vivo [88] and pharmacological Pim-1 inhibition abrogates the cardioprotection by ischemic preconditioning [120] .
With Pim-1, a novel protein kinase has been identified to be increased in mitochondria after ischemia/reperfusion. Up to now, information on mitochondrial Pim-1 in ischemia/reperfusion is scarce and it is unclear whether or not pre-and/or postconditioning impacts on the mitochondrial contents of Pim-1.
Signal transducer and activator of transcription 3 (STAT3)
STAT (signal transducer and activator of transcription) proteins transduce stress signals from the plasma membrane to the nucleus, thereby acting as signaling molecules and transcriptional regulators [20] . Myocardial STAT3 is central for the cardioprotection by ischemic pre-and postconditioning [15, 53, 56, 117, 121] . The localization of STAT3 is not restricted to the cytosol and the nucleus; the protein is also detected in mitochondria [58, 134] , predominantly in the mitochondrial matrix [21] . Both genetic reduction and pharmacological inhibition of mitochondrial STAT3 reduce ADP-stimulated respiration of myocardial mitochondria [21, 134] . In addition to its impact on oxygen consumption, mitochondrial STAT3 inhibits calcium induced MPTP opening [21] . Despite the co-immunoprecipitation of STAT3 with cyclophilin D, cyclophilin D functions downstream of STAT3; accordingly, the cyclophilin D inhibitor cyclosporine A reduces infarct size to a similar extent in wild-type and STAT3-knockout mice in vivo [21] .
The important role of STAT3 in cardioprotection may be in part mediated by its effects on mitochondrial respiration and MPTP opening. However, whether or not ischemic pre-and postconditioning induce a translocation of STAT3 into mitochondria and impact on the activity/ phosphorylation of mitochondrial STAT3 is unclear at present.
Connexin 43
Cardioprotection by ischemic and pharmacological preconditioning is dependent on the amount of connexin 43 (Cx43); accordingly, infarct size reduction by the above interventions is lost in heterozygous Cx43-deficient mice [64] . Cx43 is the predominant protein of ventricular gap junctions, which regulate electrical cell coupling in the myocardium. Gap junctions are formed by two opposing hemichannels, each consisting of six Cx43 proteins forming a ring-like structure (for a review, see [112, 118] ). Cx43 contains 4 transmembrane domains, 2 extracellular and 1 intracellular loop, as well as cytosolic amino-and carboxytermini. Several phosphorylation sites are located within the carboxyterminus, and Cx43 is the target of different kinases, among them protein kinase A (PKA), PKC, and MAP kinases (for a review, see [119] ).
In addition to its localization at the plasma membrane, Cx43 is also present at the inner membrane of cardiomyocyte subsarcolemmal mitochondria [16, 24, 107] . The pathway by which Cx43 is imported into mitochondria involves Hsp90 and Tom20 [107] . Since inhibition of Hsp90 by geldanamycin reduces the mitochondrial Cx43 content in hearts perfused under normoxic conditions, it is possible that Cx43 is continuously imported into mitochondria. Whether the half life of mitochondrial Cx43 is similar to that of gap junctional Cx43 (about 90 min [11] ) is unknown at present. Within mitochondria, Cx43 coimmunoprecipitates with GSK3β [112] .
Stimulation of mitochondrial potassium influx via the -not yet at the molecular level characterized -ATP-dependent mitochondrial potassium channel (mitoK ATP channel) is cardioprotective [36, 38] , and activation of the mitoK ATP channel is mediated by mitochondrial PKCε [37, 70] . Both genetic reduction and pharmacological inhibition of Cx43 decrease the mitochondrial potassium influx [87] and reduce the open probability of the mitoK ATP channel in response to the mitoK ATP opener diazoxide [109] . However, since the open probability of the channel is not dependent on Cx43 under basal conditions, it is unlikely that Cx43 represents the pore forming unit of the mitoK ATP channel [109] . Mitochondrial PKCε phosphorylates Cx43 and the PKCε-mediated activation of the mitoK ATP channel requires Cx43 [109] . Opening of the mitoK ATP channel contributes to cardioprotection via the formation of small amounts of ROS, which function as trigger molecules of preconditioning [2, 100] . Cardiomyocytes from heterozygous Cx43-deficient mice do not form sufficient amounts of ROS in response to diazoxide and accordingly have no infarct size reduction after ischemia/reperfusion in vivo [64] .
Ischemic preconditioning increases the amount of mitochondrial Cx43 after short preconditioning cycles of ischemia/reperfusion in rat hearts in vitro and after sustained ischemia in pig hearts in vivo [16] . In pig myocardium, ischemia/reperfusion is associated with increased dephosphorylation of mitochondrial Cx43, and ischemic preconditioning preserves Cx43 phosphorylation at the epitope Ser368 [126] . However, enhanced mitochondrial Cx43 content following preconditioning is no prerequisite for cardioprotection. It is rather the decrease of Cx43 below a certain threshold level which must be avoided to preserve the protection of the myocardium by preconditioning. In rat hearts in vitro, diazoxide reduces infarct size without impact on the mitochondrial Cx43 content. In contrast, geldanamycin reduces the amount of mitochondrial Cx43 and abolishes the cardioprotection by diazoxide in rat hearts [107] . In bone marrow derived stem cell antigen-1 (Sca-1)-positive stem cells, preconditioning with insulinlike growth factor-1 (IGF-1) is associated with enhanced translocation of Cx43 to the inner mitochondrial membrane [81] . Mitochondriaspecific overexpression of Cx43 in Sca-1 positive cells reduces apoptosis and necrosis by oxygen glucose deprivation [82] .
The role of mitochondrial Cx43 in ischemic postconditioning has not been characterized in detail up to now. Penna and coworkers demonstrated decreased amounts of total Cx43 in mitochondria, which were isolated from postconditioned (5 cycles of 10 s ischemia and reperfusion each) rat hearts undergoing 30 min ischemia and 120 min reperfusion in vitro [102] . The reduced amounts of total Cx43 were paralleled by reduced amounts of Cx43 phosphorylated at Ser368. We have investigated the Cx43 content in mitochondria from mouse hearts undergoing 30 min ischemia and 10 min reperfusion without and with ischemic postconditioning by 3 cycles of 10 s ischemia and reperfusion each in vivo. Here, ischemic postconditioning increased both the level of total Cx43 and of Cx43 phosphorylated at Ser368 (Fig. 1) . However, changes in the amount of total Cx43 or phosphorylated Cx43 may be an epiphenomenon associated with ischemic postconditioning, since ischemic postconditioning reduces infarct size in heterozygous Cx43-deficient hearts to a similar extent as in wild-type hearts [67] . Taken together, mitochondrial Cx43 is important for ischemic preconditioning via modulation of the opening of mitoK ATP channels and subsequent ROS formation. Physiological amounts of mitochondrial Cx43 are important for effective cardioprotection by ischemic and pharmacological preconditioning but most likely not by postconditioning.
Mitochondrial protein import under pathophysiological conditions
An interaction of mitochondrial proteins encoded in the nucleus and in the mitochondria is necessary for proper mitochondrial function and defective import of mitochondrial proteins causes mitochondrial dysfunction. The protein import into mitochondria can be impaired by mutations in DNA encoding mitochondrial target sequences or proteins of the import machinery. In addition, differential expression of genes encoding proteins involved in mitochondrial protein import or folding can alter protein import and thereby cause various diseases (for a review, see [84] ).
With aging, the transcription of genes encoding proteins with different functions -among them subunits of the electron transport chain [14] -is reduced, contributing to the development of mitochondrial dysfunction (for a review, see [23] ). The amounts of nuclearencoded mitochondrial proteins which are important for cardioprotection are also affected by age [23] . For example, the amounts of Cx43 and STAT3 are reduced both in ventricular total protein extracts and in mitochondria isolated from aged mice [21, 22] . Since both proteins coimmunoprecipitate with the presequence receptor Tom20, the decreased mitochondrial Tom20 content in mitochondria isolated from aged mouse hearts may -at least in part -contribute to the reduced mitochondrial contents of Cx43 and STAT3 [22] . However, the mitochondrial import of precursor proteins obtained by in vitro transcription is not impaired in aged myocardium, and the amounts of the matrix chaperones Hsp70 and Hsp60 are not altered in aged hearts [39] . Therefore, the reduced mitochondrial contents of proteins involved in cardioprotection might be due to a combination of altered gene transcription and mitochondrial protein import.
Mitochondrial dysfunction is associated with diabetes mellitus types 1 and 2 [26, 41, 114] , and the mitochondrial proteome changes with diabetes. For example, proteins important for β-oxidation are upregulated at 1 and 4 weeks after induction of diabetes type 1 by the injection of streptozotocin (Stz) [127] . One week after Stz injection, the mitochondrial amounts of Hsp60 and Hsp70 are reduced [127] . Reduced amounts of cardiac mitochondrial Hsp70 are also detected 5 weeks after Stz injection [9] , but not 8 weeks after Stz treatment [62] . The decrease of mitochondrial Hsp70 5 weeks after Stz injection is more pronounced in mitochondria located between the myofibrils (interfibrillar mitochondria, IFM) than in mitochondria present beneath the sarcolemma (subsarcolemmal mitochondria, SSM), and it is associated with reduced mitochondrial protein import [9] . Similarly, mitochondrial Hsp70 is downregulated in SSM in a type 2 model of diabetes in mice with a mutated leptin receptor [40] .
Taken together, the mitochondrial proteome is altered under pathophysiological conditions, and these changes may be due to a combination of differential expression of nuclear-encoded mitochondrial proteins and alterations of the mitochondrial import machinery itself. -overload at reperfusion induces mitochondrial permeability transition pore (PTP) opening and thereby necrotic and apoptotic cell death. Small amounts of reactive oxygen species (ROS), which function as trigger molecules of preconditioning, are generated by opening of the mitochondrial ATP-dependent potassium channel (K ATP ). K ATP opening is regulated by protein kinase C epsilon (PKCε) via phosphorylation of connexin 43 (Cx43). Excessive amounts of ROS, produced by a dysfunctional electron transport chain (ETC), by p66 Shc , and/or by monoamine oxidases (MAO) modify proteins (ox) involved in mitochondrial network formation and interaction between mitochondria and the endoplasmic/sarcoplasmic reticulum, such as mitofusin 2 (Mfn2), dynamin-related protein 1 (Drp1), optic atrophy protein 1 (Opa1), and damage mitochondrial proteins and structure and thereby enhance cell death. Furthermore, ROS facilitate PTP opening via translocation of cyclophilin D (CypD) from the matrix to the PTP. PTP opening is facilitated by glycogen synthase kinase 3 β (GSK3β). The role of mitochondrial signal transducer and activator of transcription 3 (STAT3) in the mitochondrial matrix needs to be investigated in more detail.
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Conclusion
Mitochondria are both a target and a source of ischemia/reperfusion injury, and the cardioprotective mechanisms of ischemic and pharmacological pre-and postconditioning decisively involve the mitochondria. To allow for cardioprotection, several proteins have to be imported into the mitochondria, and the proteins of the mitochondrial import machinery itself contribute to cardioprotection. However, detailed information on the molecular identity of the proteins imported into mitochondria, the regulation of the mitochondrial import machinery itself, and putative interrelations between the translocated proteins upon a cardioprotective stimulus is not available up to now. Therefore, the identification of common denominators of the signaling pathways influencing the import of proteins into mitochondria after ischemia/ reperfusion is challenging at present. In contrast to the sparse information on how mitochondrial protein import is regulated by cardioprotective stimuli, the impact of cardioprotective maneuvers on mitochondrial function is more explicitly characterized, and a scheme on the role of mitochondria in ischemia/reperfusion injury and in cardioprotection is demonstrated in Fig. 2 . Encouraging clinical data suggest that patients with acute myocardial infarction also benefit from preserved mitochondrial function [104] , thereby emphasizing the importance of mitochondria as therapeutical targets to limit ischemia/ reperfusion injury. 
